首页> 外文期刊>Journal of Thoracic Disease >Safety and feasibility of uniportal video-assisted thoracoscopic surgery for locally advanced non-small cell lung cancer
【24h】

Safety and feasibility of uniportal video-assisted thoracoscopic surgery for locally advanced non-small cell lung cancer

机译:单门电视胸腔镜手术治疗局部晚期非小细胞肺癌的安全性和可行性

获取原文
           

摘要

Background: Conventional video-assisted thoracoscopic surgery (VATS) lobectomy for locally advanced non-small cell lung cancer (NSCLC) is a feasible and safe surgery in high-volume centers with significant VATS experience. Uniportal VATS lobectomy has been recently been reported to be a promising, less invasive approach. The purpose of this study is to explore the safety and feasibility of uniportal video-assisted thoracoscopic surgery (U-VATS) for the treatment of patients with locally advanced NSCLC. Methods: From January 2013 to September 2015, a total of 132 patients with locally advanced NSCLC underwent U-VATS or open thoracotomy major pulmonary resections and standard mediastinal lymph node dissection. Patients were divided into two groups: (I) locally advanced NSCLC underwent U-VATS (U-VATS); (II) locally advanced NSCLC underwent open thoracotomy (open). A descriptive and retrospective study was performed, including the operative time, operative blood loss, postoperative chest tube duration, postoperative hospital stay, lymph node dissection, postoperative complications and postoperative recovery. Results: A total of 132 patients with locally advanced NSCLC were included in this study: 64 (U-VATS) vs. 68 (open) patients. The patient demographic data was similar in both groups. Median operative time (157.0 vs. 160.6) and median number of lymph nodes (35.5 vs . 32.5) were similar in both groups. Chest tube duration and hospital of stay were statistically shorter in U-VATS group while rate of complications were higher in open thoracotomy group. One patient died on the 55 th postoperative day because of tumor metastasis and bronchopleural fistula. A higher percentage of patients who underwent UVATS resections were able to receive adjuvant therapy timely compared to the open group. Conclusions: Uniportal VATS major pulmonary resections and mediastinal lymph node dissection is a safe and feasible procedure for the treatment of locally advanced NSCLC. Particularly it is suitable for the frail patients with locally advanced NSCLC who require comprehensive treatment.
机译:背景:用于局部晚期非小细胞肺癌(NSCLC)的常规电视胸腔镜手术(VATS)肺叶切除术是在具有大量VATS经验的高容量中心的可行且安全的手术。最近有报道称单门VATS肺叶切除术是一种有前途的,侵入性较小的方法。这项研究的目的是探讨单门电视辅助胸腔镜手术(U-VATS)治疗局部晚期NSCLC患者的安全性和可行性。方法:2013年1月至2015年9月,共132例局部晚期NSCLC患者接受了U-VATS或开放式开胸大肺切除术和标准的纵隔淋巴结清扫术。患者分为两组:(I)局部晚期NSCLC接受了U-VATS(U-VATS); (二)局部晚期非小细胞肺癌行开胸手术(开腹)。进行了一项描述性和回顾性研究,包括手术时间,手术失血量,术后胸管持续时间,术后住院时间,淋巴结清扫,术后并发症和术后恢复情况。结果:本研究共纳入132例局部晚期NSCLC患者:64例(U-VATS)与68例(开放性)患者。两组患者的人口统计学数据相似。两组的中位手术时间(157.0 vs. 160.6)和淋巴结中位数(35.5 vs. 32.5)相似。 U-VATS组胸管持续时间和住院时间在统计学上较短,而开胸手术组的并发症发生率较高。 1例患者在术后第55天因肿瘤转移和支气管胸膜瘘而死亡。与开放组相比,接受UVATS切除术的患者能够及时接受辅助治疗的比例更高。结论:单门VATS大肺切除术和纵隔淋巴结清扫术是治疗局部晚期NSCLC的安全可行的方法。特别适合需要全面治疗的局部晚期NSCLC体弱的患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号